Static Chart ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Equities

Market Closed - Hong Kong S.E. Other stock markets 03:58:02 2024-07-18 am EDT			5-day change	1st Jan Change
12.9 ^HKD	+0.31%		-0.62%	-56.86%

Jul. 03	ImmuneOnco Doses First Patient in Phase 3 Clinical Trial of Hodgkin Lymphoma Drug	MT
Jul. 03	ImmuneOnco Biopharmaceuticals Inc. Announces Updates on the Clinical Trial of IMM01 (Timdarpacept) in Combination with Tislelizumab	CI

Duration

Period